Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein A-I Mimetic Peptides: Discordance Between In Vitro and In Vivo Properties-Brief Report.

Arteriosclerosis, thrombosis, and vascular biology - 1 Jul 2017

Ditiatkovski Michael, Palsson Jonatan, Chin-Dusting Jaye, Remaley Alan T, Sviridov Dmitri

Abstract excerpt

OBJECTIVE: Apolipoprotein A-I (apoA-I) mimetic peptides have antiatherogenic properties of high-density lipoprotein in vitro and have been shown to inhibit atherosclerosis in vivo. It is unclear, however, if each in vitro antiatherogenic property of these peptides translates to a corresponding activity in vivo, and if so, which of these contributes most to reduce atherosclerosis. APPROACH AND RESULTS: The effect...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aortic Diseases
Share to Apolipoprotein A-I

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diet, High-Fat

Share to Hypolipidemic Agents

Share to Lipoproteins

Share to Plaque, Atherosclerotic

Share to RAW 264.7 Cells

Share to Tissue Distribution

Source

Open in PubMed Open full text

Identifiers

PMID: 28522696
DOI: 10.1161/ATVBAHA.117.309523
PMCID: PMC5505773

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein A-I Mimetic Peptides: Discordance Between In Vitro and In Vivo Properties-Brief Report.PMID 28522696Read ↗

Modifications of the 22A apoA-I mimetic peptide sequence improve the anti-atherosclerotic properties of synthetic HDLSemantic proximity Read ↗

The Role of An Experimental Model of Atherosclerosis: apoE-knockout Mice in Developing New Drugs against AtherogenesisSemantic proximity Read ↗

A Unique Combination of Nutritionally Active Ingredients Can Prevent Several Key Processes Associated with Atherosclerosis In Vitro.Semantic proximity Read ↗

The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis.Semantic proximity Read ↗

Comparative Effects of Diet-Induced Lipid Lowering Versus Lipid Lowering Along With Apo A-I Milano Gene Therapy on Regression of Atherosclerosis.Semantic proximity Read ↗

Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice.Semantic proximity Read ↗

Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages.Semantic proximity Read ↗

Apolipoprotein A-I(Milano): current perspectives.Semantic proximity Read ↗

Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.Semantic proximity Read ↗

The anti-atherosclerosis effect of anakinra, a recombinant human interleukin-1 receptor antagonist, in apolipoprotein E knockout miceSemantic proximity Read ↗

Mipomersen, an Antisense Oligonucleotide to Apolipoprotein B-100, Reduces Lipoprotein(a) in Various Populations With HypercholesterolemiaSemantic proximity Read ↗

ABCA1 (ATP-Binding Cassette Transporter A1) Mediates ApoA-I (Apolipoprotein A-I) and ApoA-I Mimetic Peptide Mobilization of Extracellular Cholesterol Microdomains Deposited by Macrophages.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.